Clinical Trials Directory

Trials / Completed

CompletedNCT03833102

Prospective Study of Staphylococcus Aureus Clinical Isolates Versus Colonization: RNAs as Potential Biomarkers for Bloodstream Infections

Status
Completed
Phase
Study type
Observational
Enrollment
165 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to demonstrate that the risk of S. aureus bacteremia (SAB) is correlated to the RNA III and SprD RNAs expression

Detailed description

Staphylococcus aureus ranks among the top three organisms for community-acquired, healthcare-related and nosocomial infections in humans. It lives as a commensal organism but can also provoke very severe diseases. Identifying markers of the 'colonization/disease' transition is of paramount importance. We recently found that an association of two regulatory RNAs was associated with S. aureus infection rather than colonization and with the severity of infection. Those preliminary results have to be confirmed with a more important prospective cohort.

Conditions

Interventions

TypeNameDescription
OTHERbiological analysisST types will be determined for all individualized bacterial strains. For all the bacterial strains, RNAs expression will be analyzed at three different growth phases: early exponential phase, mid exponential phase and early stationary phase. Expression of RNAIII and SprD will be evaluated by quantitative polymerase chain reaction.

Timeline

Start date
2018-02-21
Primary completion
2022-11-22
Completion
2023-02-22
First posted
2019-02-06
Last updated
2023-04-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03833102. Inclusion in this directory is not an endorsement.